Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiziana Martino

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 17, 2004
New Huntington disease mutation arising from a paternal CAG34 allele showing somatic length variation in serially passaged lymphoblastsMilena Cannella, Vittorio Maglione, Tiziana Martino, et al.
Neuroscience Letters|October 14, 2005
The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant choreaVittorio Maglione, Milena Cannella, Tiziana Martino, et al.
BMC Medical Genetics|February 13, 2009
DNA instability in replicating Huntington's disease lymphoblastsMilena Cannella, Vittorio Maglione, Tiziana Martino, et al.
BMJ Case Reports|June 21, 2011
De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementiaM Cannella, Tiziana Martino, Maria Simonelli, et al.
Journal of the Neurological Sciences|December 9, 2008
Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?Yuval O Herishanu, Ruti Parvari, Yaakov Pollack, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 13, 2009
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophinsFerdinando Squitieri, Sara Orobello, Milena Cannella, et al.
CNS Neuroscience & Therapeutics|February 21, 2009
Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's diseaseFerdinando Squitieri, Milena Cannella, Maria Simonelli, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 24, 2012
Further evidence of reliability and validity of the Huntington's disease quality of life battery for carers: Italian and French translationsAimee Aubeeluck, Julie Dorey, Ferdinando Squitieri, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 19, 2007
Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutationsFernando Gianfrancesco, Milena Cannella, Tiziana Martino, et al.
International Clinical Psychopharmacology|April 18, 2012
Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life InstrumentEmilie Clay, Annunziata De Nicola, Julie Dorey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|November 17, 2004
New Huntington disease mutation arising from a paternal CAG34 allele showing somatic length variation in serially passaged lymphoblastsMilena Cannella, Vittorio Maglione, Tiziana Martino, et al.
Neuroscience Letters|October 14, 2005
The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant choreaVittorio Maglione, Milena Cannella, Tiziana Martino, et al.
BMC Medical Genetics|February 13, 2009
DNA instability in replicating Huntington's disease lymphoblastsMilena Cannella, Vittorio Maglione, Tiziana Martino, et al.
BMJ Case Reports|June 21, 2011
De novo seven extra repeat expanded mutation in the PRNP gene in an Italian patient with early onset dementiaM Cannella, Tiziana Martino, Maria Simonelli, et al.
Journal of the Neurological Sciences|December 9, 2008
Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy?Yuval O Herishanu, Ruti Parvari, Yaakov Pollack, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 13, 2009
Riluzole protects Huntington disease patients from brain glucose hypometabolism and grey matter volume loss and increases production of neurotrophinsFerdinando Squitieri, Sara Orobello, Milena Cannella, et al.
CNS Neuroscience & Therapeutics|February 21, 2009
Distinct brain volume changes correlating with clinical stage, disease progression rate, mutation size, and age at onset prediction as early biomarkers of brain atrophy in Huntington's diseaseFerdinando Squitieri, Milena Cannella, Maria Simonelli, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 24, 2012
Further evidence of reliability and validity of the Huntington's disease quality of life battery for carers: Italian and French translationsAimee Aubeeluck, Julie Dorey, Ferdinando Squitieri, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 19, 2007
Highly variable penetrance in subjects affected with cavernous cerebral angiomas (CCM) carrying novel CCM1 and CCM2 mutationsFernando Gianfrancesco, Milena Cannella, Tiziana Martino, et al.
International Clinical Psychopharmacology|April 18, 2012
Validation of the first quality-of-life measurement for patients with Huntington's disease: the Huntington Quality of Life InstrumentEmilie Clay, Annunziata De Nicola, Julie Dorey, et al.
Pageof 1